Skip to main content
Top
Published in: Clinical Reviews in Allergy & Immunology 3/2012

01-12-2012

Behçet Syndrome: Is It One Condition?

Authors: H. Yazici, S. Ugurlu, E. Seyahi

Published in: Clinical Reviews in Allergy & Immunology | Issue 3/2012

Login to get access

Abstract

Behçet's syndrome (BS) is a disease of unknown etiology, and as such, there have been efforts to classify BS within the popular nosological identities of the times such as seronegative spondarthritides, autoimmune, and more recently autoinflammatory diseases. Current evidence suggests that BS does not easily fit into any one of these lumps, while on occasion, it might be impossible to tell BS from Crohn's disease, especially when the main clinical presentation is intestinal ulceration. There are distinct regional differences in disease expression of BS with fewer cases of intestinal disease in the Mediterranean basin and less severe eye disease and less frequent skin pathergy among patients reported from northern Europe or America. The clustering of symptoms, especially with the recently described increased frequency of the acne/arthritis cluster in familial cases, suggests that more than one pathological pathway is involved in what we call BS today. Supportive evidence for this contention also comes from the observations that (a) the genetic component is very complex with perhaps different genetic modes of inheritance in the adult and in the pediatric patients; and (b) there are differing organ responses to one same drug. For example, the anti-TNF agents successfully control the oral ulcers while they have no effect on the pathergy reaction.
Literature
1.
go back to reference Kural-Seyahi E, Fresko I, Seyahi N et al (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60–76CrossRef Kural-Seyahi E, Fresko I, Seyahi N et al (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60–76CrossRef
2.
go back to reference Yazici H (1978) Behcet's disease. Br Med J 2:952 Yazici H (1978) Behcet's disease. Br Med J 2:952
3.
go back to reference Mizushima Y (1988) Recent research into Behçet's disease in Japan. Int J Tissue React 10:59–65PubMed Mizushima Y (1988) Recent research into Behçet's disease in Japan. Int J Tissue React 10:59–65PubMed
4.
go back to reference Cheon JH, Celik AF, Kim W (2010) Behçet's disease: gastrointestinal involvement. In: Yazici Y, Yazici H (eds) Behçet's syndrome, 1st edn. Springer, New York, pp 165–189CrossRef Cheon JH, Celik AF, Kim W (2010) Behçet's disease: gastrointestinal involvement. In: Yazici Y, Yazici H (eds) Behçet's syndrome, 1st edn. Springer, New York, pp 165–189CrossRef
5.
go back to reference International Study Group for Behçet's Disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335:1078–1080 International Study Group for Behçet's Disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335:1078–1080
6.
go back to reference Moll JM, Haslock I, Macrae IF, Wright V (1974) Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome. Medicine (Baltimore) 53:343–364CrossRef Moll JM, Haslock I, Macrae IF, Wright V (1974) Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome. Medicine (Baltimore) 53:343–364CrossRef
7.
go back to reference Yazici H, Tuzlaci M, Yurdakul S (1981) A controlled survey of sacroiliitis in Behcet's disease. Ann Rheum Dis 40:558–559PubMedCrossRef Yazici H, Tuzlaci M, Yurdakul S (1981) A controlled survey of sacroiliitis in Behcet's disease. Ann Rheum Dis 40:558–559PubMedCrossRef
8.
go back to reference Yazici H, Chamberlain MA, Schreuder I, D'Amaro J, Muftuoglu M (1980) HLA antigens in Behçet's disease: a reappraisal by a comparative study of Turkish and British patients. Ann Rheum Dis 39:344–348PubMedCrossRef Yazici H, Chamberlain MA, Schreuder I, D'Amaro J, Muftuoglu M (1980) HLA antigens in Behçet's disease: a reappraisal by a comparative study of Turkish and British patients. Ann Rheum Dis 39:344–348PubMedCrossRef
9.
go back to reference Ohno S, Aoki K, Sugiura S, Nakayama E, Itakura K, Aizawa M (1973) HL-A5 and Behcet's disease. Lancet 2:1383–1384CrossRef Ohno S, Aoki K, Sugiura S, Nakayama E, Itakura K, Aizawa M (1973) HL-A5 and Behcet's disease. Lancet 2:1383–1384CrossRef
10.
go back to reference Diri E, Mat C, Hamuryudan V, Yurdakul S, Hizli N, Yazici H (2001) Papulopustular skin lesions are seen more frequently in patients with Behçet's syndrome who have arthritis: a controlled and masked study. Ann Rheum Dis 60:1074–1076PubMedCrossRef Diri E, Mat C, Hamuryudan V, Yurdakul S, Hizli N, Yazici H (2001) Papulopustular skin lesions are seen more frequently in patients with Behçet's syndrome who have arthritis: a controlled and masked study. Ann Rheum Dis 60:1074–1076PubMedCrossRef
11.
go back to reference Tunc R, Keyman E, Melikoglu M, Fresko I, Yazici H (2002) Target organ associations in Turkish patients with Behçet's disease: a cross sectional study by exploratory factor analysis. J Rheumatol 29:2393–2396PubMed Tunc R, Keyman E, Melikoglu M, Fresko I, Yazici H (2002) Target organ associations in Turkish patients with Behçet's disease: a cross sectional study by exploratory factor analysis. J Rheumatol 29:2393–2396PubMed
12.
go back to reference Hatemi G, Bahar H, Uysal S et al (2004) The pustular skin lesions in Behcet's syndrome are not sterile. Ann Rheum Dis 63:1450–1452PubMedCrossRef Hatemi G, Bahar H, Uysal S et al (2004) The pustular skin lesions in Behcet's syndrome are not sterile. Ann Rheum Dis 63:1450–1452PubMedCrossRef
13.
go back to reference Hatemi G, Fresko I, Tascilar K, Yazici H (2008) Increased enthesopathy among Behçet's syndrome patients with acne and arthritis: an ultrasonography study. Arthritis Rheum 58:1539–1545PubMedCrossRef Hatemi G, Fresko I, Tascilar K, Yazici H (2008) Increased enthesopathy among Behçet's syndrome patients with acne and arthritis: an ultrasonography study. Arthritis Rheum 58:1539–1545PubMedCrossRef
14.
go back to reference Hatemi G, Fresko I, Yurdakul S et al (2010) Reply to letter by Priori et al commenting on whether Behçet's syndrome patients with acne and arthritis comprise a true subset. Arthritis Rheum 62:305–306PubMedCrossRef Hatemi G, Fresko I, Yurdakul S et al (2010) Reply to letter by Priori et al commenting on whether Behçet's syndrome patients with acne and arthritis comprise a true subset. Arthritis Rheum 62:305–306PubMedCrossRef
15.
16.
go back to reference Krause I, Leibovici L, Guedj D, Molad Y, Uziel Y, Weinberger A (1999) Disease patterns of patients with Behçet's disease demonstrated by factor analysis. Clin Exp Rheumatol 17:347–350PubMed Krause I, Leibovici L, Guedj D, Molad Y, Uziel Y, Weinberger A (1999) Disease patterns of patients with Behçet's disease demonstrated by factor analysis. Clin Exp Rheumatol 17:347–350PubMed
17.
go back to reference Tunc R, Saip S, Siva A, Yazici H (2004) Cerebral venous thrombosis is associated with major vessel disease in Behçet's syndrome. Ann Rheum Dis 63:1693–1694PubMedCrossRef Tunc R, Saip S, Siva A, Yazici H (2004) Cerebral venous thrombosis is associated with major vessel disease in Behçet's syndrome. Ann Rheum Dis 63:1693–1694PubMedCrossRef
18.
go back to reference Seyahi E, Melikoglu M, Akman C et al (2012) Pulmonary artery involvement and associated lung disease in Behçet disease: a series of 47 patients. Medicine (Baltimore) 91:35–48CrossRef Seyahi E, Melikoglu M, Akman C et al (2012) Pulmonary artery involvement and associated lung disease in Behçet disease: a series of 47 patients. Medicine (Baltimore) 91:35–48CrossRef
19.
go back to reference Uzun O, Akpolat T, Erkan L (2005) Pulmonary vasculitis in Behcet disease: a cumulative analysis. Chest 127:2243–2253PubMedCrossRef Uzun O, Akpolat T, Erkan L (2005) Pulmonary vasculitis in Behcet disease: a cumulative analysis. Chest 127:2243–2253PubMedCrossRef
20.
go back to reference Melikoglu M, Ugurlu S, Tascilar K et al (2008) Large vessel involvement in Behcet's syndrome: a retrospective survey. Ann Rheum Dis 67(Suppl 2):67 Melikoglu M, Ugurlu S, Tascilar K et al (2008) Large vessel involvement in Behcet's syndrome: a retrospective survey. Ann Rheum Dis 67(Suppl 2):67
21.
go back to reference Rose NR, Bona C (1993) Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 14:426–430PubMedCrossRef Rose NR, Bona C (1993) Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 14:426–430PubMedCrossRef
22.
go back to reference Yazici H (1997) The place of Behçet's syndrome among the autoimmune diseases. Int Rev Immunol 14:1–10PubMedCrossRef Yazici H (1997) The place of Behçet's syndrome among the autoimmune diseases. Int Rev Immunol 14:1–10PubMedCrossRef
23.
go back to reference Oran M, Hatemi G, Tasli L et al (2008) Behçet's syndrome is not associated with vitiligo. Clin Exp Rheumatol 26(Suppl 50):107–109 Oran M, Hatemi G, Tasli L et al (2008) Behçet's syndrome is not associated with vitiligo. Clin Exp Rheumatol 26(Suppl 50):107–109
24.
go back to reference Seyahi E, Yazici H (2007) Atherosclerosis in Behçet's syndrome. Clin Exp Rheumatol 25(Suppl 45):1–5 Seyahi E, Yazici H (2007) Atherosclerosis in Behçet's syndrome. Clin Exp Rheumatol 25(Suppl 45):1–5
25.
go back to reference Gül A (2005) Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4:81–83PubMedCrossRef Gül A (2005) Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4:81–83PubMedCrossRef
26.
go back to reference Yazici H, Fresko I (2005) Behçet's disease and other autoinflammatory conditions: what's in a name? Clin Exp Rheumatol 23(Suppl 38):1–2 Yazici H, Fresko I (2005) Behçet's disease and other autoinflammatory conditions: what's in a name? Clin Exp Rheumatol 23(Suppl 38):1–2
27.
go back to reference Kurokawa T, Kikuchi T, Ohta K, Imai H, Yoshimura N (2003) Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology 110:2040–2044PubMedCrossRef Kurokawa T, Kikuchi T, Ohta K, Imai H, Yoshimura N (2003) Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology 110:2040–2044PubMedCrossRef
28.
go back to reference Toro JR, Aksentijevich I, Hull K, Dean J, Kastner DL (2000) Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations. Arch Dermatol 136:1487–1494PubMedCrossRef Toro JR, Aksentijevich I, Hull K, Dean J, Kastner DL (2000) Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations. Arch Dermatol 136:1487–1494PubMedCrossRef
29.
go back to reference Dollfus H, Häfner R, Hofmann HM et al (2000) Chronic infantile neurological cutaneous and articular/neonatal onset multisystem inflammatory disease syndrome: ocular manifestations in a recently recognized chronic inflammatory disease of childhood. Arch Ophthalmol 118:1386–1392PubMedCrossRef Dollfus H, Häfner R, Hofmann HM et al (2000) Chronic infantile neurological cutaneous and articular/neonatal onset multisystem inflammatory disease syndrome: ocular manifestations in a recently recognized chronic inflammatory disease of childhood. Arch Ophthalmol 118:1386–1392PubMedCrossRef
30.
go back to reference Shimizu T, Ehrlich GE, Inaba G, Hayashi K (1979) Behçet's disease (Behçet's syndrome). Semin Arthritis Rheum 8:223–260PubMedCrossRef Shimizu T, Ehrlich GE, Inaba G, Hayashi K (1979) Behçet's disease (Behçet's syndrome). Semin Arthritis Rheum 8:223–260PubMedCrossRef
31.
go back to reference Chang HK, Kim JW (2002) The clinical features of Behçet's disease in Yongdong district: analysis of a cohort followed from 1997 to 2001. J Korean Med Sci 17:784–789PubMed Chang HK, Kim JW (2002) The clinical features of Behçet's disease in Yongdong district: analysis of a cohort followed from 1997 to 2001. J Korean Med Sci 17:784–789PubMed
32.
go back to reference Yurdakul S, Tuzuner N, Yurdakul I, Hamuryudan V, Yazici H (1996) Gastrointestinal involvement in Behçet's syndrome: a controlled study. Ann Rheum Dis 55:208–210PubMedCrossRef Yurdakul S, Tuzuner N, Yurdakul I, Hamuryudan V, Yazici H (1996) Gastrointestinal involvement in Behçet's syndrome: a controlled study. Ann Rheum Dis 55:208–210PubMedCrossRef
33.
go back to reference Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M (2004) Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol 138:373–380PubMedCrossRef Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M (2004) Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol 138:373–380PubMedCrossRef
34.
go back to reference Salvarani C, Pipitone N, Catanoso MG et al (2007) Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. Arthritis Rheum 57:171–178PubMedCrossRef Salvarani C, Pipitone N, Catanoso MG et al (2007) Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. Arthritis Rheum 57:171–178PubMedCrossRef
35.
go back to reference Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM (2009) Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study. Arthritis Rheum 61:600–604PubMedCrossRef Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM (2009) Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study. Arthritis Rheum 61:600–604PubMedCrossRef
36.
go back to reference Yazici Y, Filopoulos MT, Schimmel E, McCraken A, Swearingen C (2010) Clinical characteristics, treatment and ethnic/racial differences in the manifestations of 518 Behcet's syndrome patients in the United States. Arthritis Rheum 62(Suppl 10):535 Yazici Y, Filopoulos MT, Schimmel E, McCraken A, Swearingen C (2010) Clinical characteristics, treatment and ethnic/racial differences in the manifestations of 518 Behcet's syndrome patients in the United States. Arthritis Rheum 62(Suppl 10):535
37.
go back to reference Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y (2011) Characteristics of vascular involvement in Behçet's disease in Japan: a retrospective cohort study. Clin Exp Rheumatol 29(Suppl 67):47–53 Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y (2011) Characteristics of vascular involvement in Behçet's disease in Japan: a retrospective cohort study. Clin Exp Rheumatol 29(Suppl 67):47–53
38.
go back to reference Han JK, Kim HK, Kim YJ et al (2009) Behçet's disease as a frequently unrecognized cause of aortic regurgitation: suggestive and misleading echocardiography findings. J Am Soc Echocardiogr 22:1269–1274PubMedCrossRef Han JK, Kim HK, Kim YJ et al (2009) Behçet's disease as a frequently unrecognized cause of aortic regurgitation: suggestive and misleading echocardiography findings. J Am Soc Echocardiogr 22:1269–1274PubMedCrossRef
39.
go back to reference Huong DL, Wechsler B, Papo T et al (1997) Endomyocardial fibrosis in Behçet's disease. Ann Rheum Dis 56:205–208PubMedCrossRef Huong DL, Wechsler B, Papo T et al (1997) Endomyocardial fibrosis in Behçet's disease. Ann Rheum Dis 56:205–208PubMedCrossRef
40.
go back to reference Yazici H, Tuzun Y, Pazarli H, Yalcin B, Yurdakul S, Muftuoglu A (1980) The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey. J Rheumatol 7:206–210PubMed Yazici H, Tuzun Y, Pazarli H, Yalcin B, Yurdakul S, Muftuoglu A (1980) The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey. J Rheumatol 7:206–210PubMed
41.
go back to reference Houman MH, Neffati H, Braham A et al (2007) Behçet's disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients. Clin Exp Rheumatol 25(Suppl 45):58–64 Houman MH, Neffati H, Braham A et al (2007) Behçet's disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients. Clin Exp Rheumatol 25(Suppl 45):58–64
42.
43.
go back to reference Moore SB, O’Duffy JD (1986) Lack of association between Behçet's disease and major histocompatibility complex II antigens in an ethnically diverse North American Caucasoid patient group. J Rheumatol 13:771–773PubMed Moore SB, O’Duffy JD (1986) Lack of association between Behçet's disease and major histocompatibility complex II antigens in an ethnically diverse North American Caucasoid patient group. J Rheumatol 13:771–773PubMed
44.
go back to reference Hamuryudan V, Mat C, Saip S et al (1998) Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 128:443–450PubMed Hamuryudan V, Mat C, Saip S et al (1998) Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 128:443–450PubMed
45.
go back to reference Yurdakul S, Mat C, Tüzün Y et al (2001) A double-blind trial of colchicine in Behçet's syndrome. Arthritis Rheum 44:2686–2692PubMedCrossRef Yurdakul S, Mat C, Tüzün Y et al (2001) A double-blind trial of colchicine in Behçet's syndrome. Arthritis Rheum 44:2686–2692PubMedCrossRef
46.
go back to reference Melikoglu M, Fresko I, Mat C et al (2005) Short-term trial of etanercept in Behcet's disease: a double blind, placebo controlled study. J Rheumatol 32:98–105PubMed Melikoglu M, Fresko I, Mat C et al (2005) Short-term trial of etanercept in Behcet's disease: a double blind, placebo controlled study. J Rheumatol 32:98–105PubMed
47.
go back to reference Gül A, Tugal-Tutkun I, Dinarello CA et al (2012) Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study. Ann Rheum Dis 71:563–566PubMedCrossRef Gül A, Tugal-Tutkun I, Dinarello CA et al (2012) Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study. Ann Rheum Dis 71:563–566PubMedCrossRef
48.
go back to reference Gül A, Inanç M, Ocal L, Aral O, Koniçe M (2000) Familial aggregation of Behcet's disease in Turkey. Ann Rheum Dis 59:622–625PubMedCrossRef Gül A, Inanç M, Ocal L, Aral O, Koniçe M (2000) Familial aggregation of Behcet's disease in Turkey. Ann Rheum Dis 59:622–625PubMedCrossRef
49.
go back to reference Bird Stewart JA (1986) Genetic analysis of families of patients with Behçet's syndrome: data incompatible with autosomal recessive inheritance. Ann Rheum Dis 45:265–268PubMedCrossRef Bird Stewart JA (1986) Genetic analysis of families of patients with Behçet's syndrome: data incompatible with autosomal recessive inheritance. Ann Rheum Dis 45:265–268PubMedCrossRef
50.
go back to reference Molinari N, Koné Paut I, Manna R, Demaille J, Daures JP, Touitou I (2003) Identification of an autosomal recessive mode of inheritance in paediatric Behçet's families by segregation analysis. Am J Med Genet A 122A:115–118PubMedCrossRef Molinari N, Koné Paut I, Manna R, Demaille J, Daures JP, Touitou I (2003) Identification of an autosomal recessive mode of inheritance in paediatric Behçet's families by segregation analysis. Am J Med Genet A 122A:115–118PubMedCrossRef
51.
go back to reference Fresko I, Soy M, Hamuryudan V et al (1998) Genetic anticipation in Behcet's syndrome. Ann Rheum Dis 57:45–48PubMedCrossRef Fresko I, Soy M, Hamuryudan V et al (1998) Genetic anticipation in Behcet's syndrome. Ann Rheum Dis 57:45–48PubMedCrossRef
52.
go back to reference Masatlioglu S, Seyahi E, Tahir Turanli E et al (2010) A twin study in Behçet's syndrome. Clin Exp Rheumatol 28(Suppl 60):62–66 Masatlioglu S, Seyahi E, Tahir Turanli E et al (2010) A twin study in Behçet's syndrome. Clin Exp Rheumatol 28(Suppl 60):62–66
53.
go back to reference Seyahi E, Tahir Turanli E, Mangan MS et al (2010) The prevalence of Behçet's syndrome, familial Mediterranean fever, HLA-B51 and MEFV gene mutations among ethnic Armenians living in Istanbul, Turkey. Clin Exp Rheumatol 28(Suppl 60):67–75 Seyahi E, Tahir Turanli E, Mangan MS et al (2010) The prevalence of Behçet's syndrome, familial Mediterranean fever, HLA-B51 and MEFV gene mutations among ethnic Armenians living in Istanbul, Turkey. Clin Exp Rheumatol 28(Suppl 60):67–75
54.
go back to reference Gül A, Hajeer AH, Worthington J, Barrett JH, Ollier WE, Silman AJ (2001) Evidence for linkage of the HLA-B locus in Behcet's disease, obtained using the transmission disequilibrium test. Arthritis Rheum 44:239–240PubMedCrossRef Gül A, Hajeer AH, Worthington J, Barrett JH, Ollier WE, Silman AJ (2001) Evidence for linkage of the HLA-B locus in Behcet's disease, obtained using the transmission disequilibrium test. Arthritis Rheum 44:239–240PubMedCrossRef
55.
go back to reference Karasneh J, Gül A, Ollier WE, Silman AJ, Worthington J (2005) Whole-genome screening for susceptibility genes in multicase families with Behçet's disease. Arthritis Rheum 52:1836–1842PubMedCrossRef Karasneh J, Gül A, Ollier WE, Silman AJ, Worthington J (2005) Whole-genome screening for susceptibility genes in multicase families with Behçet's disease. Arthritis Rheum 52:1836–1842PubMedCrossRef
56.
go back to reference Remmers EF, Cosan F, Kirino Y et al (2010) Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet 42:698–702PubMedCrossRef Remmers EF, Cosan F, Kirino Y et al (2010) Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet 42:698–702PubMedCrossRef
57.
go back to reference Mizuki N, Meguro A, Ota M et al (2010) Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet 42:703–706PubMedCrossRef Mizuki N, Meguro A, Ota M et al (2010) Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet 42:703–706PubMedCrossRef
58.
go back to reference Seyahi E, Ozdogan H (2010) Juvenile Behçet's syndrome. In: Yazici Y, Yazici H (eds) Behçet's syndrome, 1st edn. Springer, New York, pp 205–214CrossRef Seyahi E, Ozdogan H (2010) Juvenile Behçet's syndrome. In: Yazici Y, Yazici H (eds) Behçet's syndrome, 1st edn. Springer, New York, pp 205–214CrossRef
59.
go back to reference de Craen AJ, Posthuma D, Remarque EJ, van den Biggelaar AH, Westendorp RG, Boomsma DI (2005) Heritability estimates of innate immunity: an extended twin study. Genes Immun 6:167–170PubMedCrossRef de Craen AJ, Posthuma D, Remarque EJ, van den Biggelaar AH, Westendorp RG, Boomsma DI (2005) Heritability estimates of innate immunity: an extended twin study. Genes Immun 6:167–170PubMedCrossRef
Metadata
Title
Behçet Syndrome: Is It One Condition?
Authors
H. Yazici
S. Ugurlu
E. Seyahi
Publication date
01-12-2012
Publisher
Humana Press Inc
Published in
Clinical Reviews in Allergy & Immunology / Issue 3/2012
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-012-8319-x

Other articles of this Issue 3/2012

Clinical Reviews in Allergy & Immunology 3/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.